Warning Letters and Notice of Violation Letters to Pharmaceutical Companies > Warning Letters 2012
Warning Letters 2012These letters are supplied by the CDER Freedom of Electronic Information Office. This page only covers Office of Prescription Drug Promotion (formerly Division of Drug Marketing, Advertising and Communications) and CDER Headquarters Warning Letters.
- Office of Prescription Drug Promotion Letters (formerly Division of Drug Marketing, Advertising, and Communications)
- Office of Compliance/Immediate Office
- Office of Drug Security, Integrity and Recalls
Food and Drug Administration
Freedom of Information Staff (HFI-35)
5600 Fishers Lane, Rockville, MD 20857
Instructions for how to submit an FOI request can be found on the FDA FOI Page.